AIMD: Ainos, Inc. Stock

by  •  • Comments Off on AIMD: Ainos, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 11.17
Enterprise Value ($M) 23.55
Book Value ($M) 13.12
Book Value / Share 0.76
Price / Book 0.85
NCAV ($M) -10.18
NCAV / Share -0.59
Price / NCAV -1.10

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.65

Liquidity (mrq)
Quick Ratio 1.91
Current Ratio 2.00

Balance Sheet (mrq) ($M)
Current Assets 3.05
Assets 26.35
Liabilities 13.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.02
Operating Income -13.84
Net Income -14.86
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -5.81
Cash from Investing -0.13
Cash from Financing 8.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-11 13D Chun-Hsien Tsai 8.31
04-11 13D Ting Chuan Lee 7.20
04-09 13D/A Ainos Inc 10.68 0.00
03-12 13D/A Advanced Semiconductor Engineering Inc 17.00 36.19
08-21 13D Taiwan Carbon Nano Technology Corp 40.23
2024-05-06 13D/A Amarillo Biosciences Inc 63.36 76.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-05 11,264 89,585 12.57
2025-06-04 4,395 73,132 6.01
2025-06-03 13,413 197,678 6.79
2025-06-02 20,428 131,970 15.48

(click for more detail)

Similar Companies
ADTX – Aditxt, Inc. ADVM – Adverum Biotechnologies, Inc.
AGEN – Agenus Inc. AKAN – Akanda Corp.
AKBA – Akebia Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io